Reboxetine: the first selective noradrenaline re-uptake inhibitor

By Kasper S.   Giamal N.E.   Hilger E.  

Expert Opinion on Pharmacotherapy, Vol. 1, Iss. 4, 2000-05 ,pp. : 771-782

Informa Healthcare

Access to resources Recommend Favorite

Delivery of Antisense Oligodeoxynucleotide as Inhibitor of 5-Hydroxytryptamine Reuptake*

By Miller K.J.   Chattaraj S.C.   Das S.K.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 11, 1999-11 ,pp. : 631-634

Pharmaceutical Press

Access to resources Recommend Favorite

LY393558, a 5-hydroxytryptamine reuptake inhibitor and 5-HT 1B/1D receptor antagonist: effects on extracellular levels of 5-hydroxytryptamine in the guinea pig and rat

By Mitchell S.N.   Greenslade R.G.   Cooper J.  

European Journal of Pharmacology, Vol. 432, Iss. 1, 2001-11 ,pp. : 19-27

Elsevier

Access to resources Recommend Favorite

Atomoxetine: a selective noradrenaline reuptake inhibitor for the treatment of attention-deficit/hyperactivity disorder

By Kratochvil Christopher J   Vaughan Brigette S   Harrington Martin J   Burke William J  

Expert Opinion on Pharmacotherapy, Vol. 4, Iss. 7, 2003-07 ,pp. : 1165-1174

Informa Healthcare

Access to resources Recommend Favorite

Effect of fluoxetine on extracellular 5-hydroxytryptamine in rat brain. Role of 5-HT autoreceptors

By Hervas I.   Artigas F.  

European Journal of Pharmacology, Vol. 358, Iss. 1, 1998-09 ,pp. : 9-18

Elsevier

Access to resources Recommend Favorite